Potent, reversible, selective and competitive inhibitor of a CCK-inactivating serine protease (tripeptidyl peptidase II) (Ki
= 7 nM). Active in vivo
= 1.1 and 6.8 mg/kg i.v. for inhibition of liver and brain enzyme respectively).
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Sold with the permission of INSERM and UCL
Inhibitors of tripeptidyl peptidase II. 2. Generation of the first novel lead inhibitor of cholecystokinin-8-inactivating peptidase: a strategy for the design of peptidase inhibitors.
Ganellin et al.
Characterization and inhibition of a cholecystokinin-inactivating serine peptidase.
Rose et al.
Characterization and cloning of tripeptidyl peptidase II from the fruit fly, Drosophila melanogaster.
Renn et al.
The citations listed below are publications that use Tocris products. Selected citations for Butabindide oxalate include:
Showing Results 1 - 1 of 1